Your session is about to expire
← Back to Search
Novel vs Traditional Sling After Shoulder Surgery
Study Summary
This trial will compare a new type of shoulder sling to a traditional one to see which gives better patient satisfaction while still having good postoperative outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am having surgery for a shoulder injury or shoulder replacement.I have had significant neck, nerve damage, or wrist/elbow issues.I am scheduled for a corrective surgery.I do not understand English.My surgery is on my dominant hand or leg.
- Group 1: Initial Immobilization with the novel sling
- Group 2: Initial Postoperative Immobilization with the standard abduction sling
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are allowed to be included in this experiment?
"Affirmative. The information housed on clinicaltrials.gov confirms that this trial, inaugurated on March 1st 2022 and subsequently modified June 13th 2022, is actively recruiting participants from one location with a total target of 40 individuals."
Is it currently possible to enroll in this trial?
"Affirmative. The clinicaltrials.gov website confirms that this scientific investigation is presently enrolling participants; it was first advertised on March 1st 2022, with the most recent update being June 13th 2022. Forty patients must be found at a single site for successful completion of the trial."
Share this study with friends
Copy Link
Messenger